TY - JOUR
T1 - Albuminuria and Estimated GFR 5 Years After Escherichia coli O157 Hemolytic Uremic Syndrome
T2 - An Update
AU - Garg, Amit X.
AU - Salvadori, Marina
AU - Okell, Justin M.
AU - Thiessen-Philbrook, Heather R.
AU - Suri, Rita S.
AU - Filler, Guido
AU - Moist, Louise
AU - Matsell, Douglas
AU - Clark, William F.
N1 - Funding Information:
Support: The Ontario Ministry of Health and Long Term Care provided grant support for this project. Dr Garg was supported by a Clinician Scientist Award from the Canadian Institutes of Health Research.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2008/3
Y1 - 2008/3
N2 - Background: Knowledge of the long-term prognosis of patients with diarrhea-associated hemolytic uremic syndrome (HUS) is important for patient counseling and follow-up. Estimates in the literature are highly variable, and previous studies did not use a healthy control group to establish outcomes attributable to HUS. Study Design: Prospective cohort study. Setting & Participants: 19 children who recovered from HUS after contamination of their municipal water supply by Escherichia coli O157:H7. Predictor: Outcomes of children who recovered from HUS were compared with a control group of 64 children who were healthy at the time of the outbreak. Both groups were similar in their demographics and follow-up testing. Outcomes & Measurements: Proteinuria, blood pressure, glomerular filtration rate (GFR) estimated by using serum creatinine or cystatin C level, and biochemical measures 5 years after the outbreak. Results: More children who recovered from HUS showed microalbuminuria than controls (20% versus 3%; relative risk, 6.0; 95% confidence interval, 1.1 to 32.8). There were no differences between groups in blood pressure or GFR when estimated by using serum creatinine level. GFR estimated by using cystatin C level was lower after HUS compared with controls (100 versus 110 mL/min/1.73 m2; P = 0.02), but no child had a GFR less than 80 mL/min/1.73 m2. Other results, including fasting glucose, albumin, and C-reactive protein levels, did not differ between groups. Limitations: Although the homogenous nature of this outbreak is a strength, long-term results may generalize less well to patients with other strains of toxigenic E coli or in other settings. Conclusions: The prognosis of patients with HUS in this cohort was better than in other studies. Ongoing follow-up will clarify the clinical relevance of microalbuminuria and mild decreases in GFR 5 years after HUS recovery.
AB - Background: Knowledge of the long-term prognosis of patients with diarrhea-associated hemolytic uremic syndrome (HUS) is important for patient counseling and follow-up. Estimates in the literature are highly variable, and previous studies did not use a healthy control group to establish outcomes attributable to HUS. Study Design: Prospective cohort study. Setting & Participants: 19 children who recovered from HUS after contamination of their municipal water supply by Escherichia coli O157:H7. Predictor: Outcomes of children who recovered from HUS were compared with a control group of 64 children who were healthy at the time of the outbreak. Both groups were similar in their demographics and follow-up testing. Outcomes & Measurements: Proteinuria, blood pressure, glomerular filtration rate (GFR) estimated by using serum creatinine or cystatin C level, and biochemical measures 5 years after the outbreak. Results: More children who recovered from HUS showed microalbuminuria than controls (20% versus 3%; relative risk, 6.0; 95% confidence interval, 1.1 to 32.8). There were no differences between groups in blood pressure or GFR when estimated by using serum creatinine level. GFR estimated by using cystatin C level was lower after HUS compared with controls (100 versus 110 mL/min/1.73 m2; P = 0.02), but no child had a GFR less than 80 mL/min/1.73 m2. Other results, including fasting glucose, albumin, and C-reactive protein levels, did not differ between groups. Limitations: Although the homogenous nature of this outbreak is a strength, long-term results may generalize less well to patients with other strains of toxigenic E coli or in other settings. Conclusions: The prognosis of patients with HUS in this cohort was better than in other studies. Ongoing follow-up will clarify the clinical relevance of microalbuminuria and mild decreases in GFR 5 years after HUS recovery.
KW - Cohort study
KW - Escherichia coli O157
KW - chronic kidney disease
KW - diabetes
KW - hemolytic uremic syndrome
KW - hypertension
KW - proteinuria
UR - http://www.scopus.com/inward/record.url?scp=39449120049&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39449120049&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2007.10.042
DO - 10.1053/j.ajkd.2007.10.042
M3 - Article
C2 - 18295059
AN - SCOPUS:39449120049
SN - 0272-6386
VL - 51
SP - 435
EP - 444
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 3
ER -